Pay in 4 interest-free payments of $6.65 Learn more
Ships within 48 hours · Estimated delivery Aug 15 - Aug 20
To evaluate if 0.04% MMC application at the ostium enhances the outcome of non-endoscopic endonasal dacryocystorhinostomy (NEED) in individuals with primary acquired nasolacrimal duct obstruction (PANDO)
In research related to colitis and gut inflammation, KPV was able to significantly reduce the presence of inflammatory cytokines and improve tissue regeneration
The two are often combined in compounded preparations because their mechanisms complement each other
Chapa AM et al
US$ 20.63
US$ 24.80
US$ 26.88
US$ 29.71
